000 01492 a2200409 4500
005 20250517135338.0
264 0 _c20170801
008 201708s 0 0 eng d
022 _a1538-8514
024 7 _a10.1158/1535-7163.MCT-16-0445
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPathak, Rakesh K
245 0 0 _aA Prodrug of Two Approved Drugs, Cisplatin and Chlorambucil, for Chemo War Against Cancer.
_h[electronic resource]
260 _bMolecular cancer therapeutics
_c04 2017
300 _a625-636 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xchemical synthesis
650 0 4 _aApoptosis
650 0 4 _aCell Line, Tumor
650 0 4 _aChlorambucil
_xchemistry
650 0 4 _aCisplatin
_xchemistry
650 0 4 _aDrug Resistance, Neoplasm
_xdrug effects
650 0 4 _aFatty Acids
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMCF-7 Cells
650 0 4 _aMetabolic Networks and Pathways
_xdrug effects
650 0 4 _aMice
650 0 4 _aMitochondria
_xdrug effects
650 0 4 _aNanoparticles
_xchemistry
650 0 4 _aProdrugs
_xchemical synthesis
700 1 _aWen, Ru
700 1 _aKolishetti, Nagesh
700 1 _aDhar, Shanta
773 0 _tMolecular cancer therapeutics
_gvol. 16
_gno. 4
_gp. 625-636
856 4 0 _uhttps://doi.org/10.1158/1535-7163.MCT-16-0445
_zAvailable from publisher's website
999 _c26839820
_d26839820